Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-31 @ 7:05 PM
Study NCT ID:
NCT04568434
Status:
COMPLETED
Last Update Posted:
2025-03-06
First Post:
2020-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-23
First Submit QC Date:
None
Study First Post Date:
2020-09-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-13
Results First Submit QC Date:
None
Results First Post Date:
2025-03-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-05-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-02-13
Last Update Post Date:
2025-03-06
Last Update Post Date Type:
ACTUAL